Aparna Parikh, MD, MS, Discusses Balancing Physical Fitness, Family Life, and Her Work in the GI Space


Aparna Parikh, MD, MS, discusses how her early experiences with physical fitness shaped her current relationship with exercise.

Aparna Parikh's passion for fitness started early on with a love for competitive tennis in high school and college. Throughout her time in premed, Parikh continued to stay active, but it was a move to the San Francisco Bay area during her fellowship that gave her an appreciation of the great outdoors. She began biking to work and even swimming in the San Francisco Bay, leading into her first triathlon, which she completed while pregnant with her first child. In addition to discussing her passion for being physically active, she describes how she balances remaining active with saving lives at the Mass General Cancer Center in Boston, Massachusetts, and spending time with her family.

Related Videos
Implementing tax benefits for manufacturers who produce chemotherapy drugs may be one solution to increase drug production in the United States, according to Lucio N. Gordan, MD.
Lucio N. Gordan, MD, describes how his practice deals with increasing costs of limited chemotherapy agents to ensure that patients with cancer continue to receive treatment.
Lucio N. Gordan, MD, also discusses how increasing domestic manufacturing of chemotherapy may help in alleviating the ongoing shortages of carboplatin and cisplatin in the United States.
Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, believes that national legislation can help to resolve the United States’ current dearth of cisplatin, as well as prevent future problems.
Using an AUC of 5 instead of an AUC of 6 can help to conserve cisplatin among patients with cancer, Kirollos Hanna, PharmD, BCPS, BCOP, FACCC says.
While there is a cisplatin shortage in the United States, the FDA has approved the importation of select chemotherapy drugs from China to help mitigate the scarcity of the agents.
Recommendations penned by the American Society of Clinical Oncology and Society for Gynecologic Oncology may be critical in managing the ongoing chemotherapy shortage, according to Michael Ganio, PharmD, MS, BCPS, FASHP.
Chemotherapy agents imported from Chinese manufacturers may have barcodes that don’t work or be missing an NDC number, according to Michael Ganio, PharmD, MS, BCPS, FASHP.
Results of a survey from the National Comprehensive Cancer Network indicate that almost all responding institutions are experiencing a carboplatin shortage.
Although opioid use guidelines from the Centers for Disease Control exclude patients with cancer, drug screenings are required that could further contribute to racial disparities.
Related Content